Director Bruce Van Saun filed a Form 4 with the SEC on September 8, 2026, reporting two acquisition transactions in Moody's Corporation common stock dated September 4, 2026, both arising from dividend reinvestment accruals at zero cost.
A Form 4 statement of changes in beneficial ownership was filed by Eric He, a director of Agora, Inc. (NASDAQ:API), reporting a transaction dated September 1, 2026, in which restricted stock units converted into American Depositary Shares.
BioNTech SE Chief Executive Officer Ugur Sahin filed a Form 4 with the SEC on September 8, 2026, disclosing the sale of 76,500 ordinary shares across two transactions on September 3 and September 4, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Global-E Online Ltd. (NASDAQ:GLBE) President Debbi Nir filed a Form 4 on September 8, 2026, disclosing a sale of ordinary shares on September 4, 2026, executed pursuant to a Rule 10b5-1 trading plan.
Jeffrey K. Schomburger, Director and President & CEO Elect of Tyson Foods, Inc., filed a Form 4 on September 8, 2026, disclosing an open-market purchase of Class A Common Stock on September 4, 2026.
Kimberly G. Stith, Senior Vice President and Chief Human Resources Officer of Waste Management Inc., filed a statement of changes in beneficial ownership on September 8, 2026, reporting a transaction dated September 3, 2026.
A Form 4 filed with the SEC on September 8, 2026 discloses that Shahar Tamari, Chief Operating Officer and Director of Global-E Online Ltd. (NASDAQ:GLBE), disposed of 24,999 ordinary shares on September 3, 2026, pursuant to a Rule 10b5-1 trading plan.
Richard S. Kraemer, Senior Executive Vice President and Chief Financial Officer of Fulton Financial Corp, filed a Form 4 on September 8, 2026, disclosing multiple changes in beneficial ownership of common stock and restricted stock units dated as early as June 6, 2026.
A Form 4 filed on September 8, 2026, disclosed that Sean Desmond, CEO and President of nCino, Inc. (NASDAQ:NCNO), exercised stock options and sold common stock on September 3, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
A NASDAQ-listed healthcareRoyaltycompany is trading sharply lower today despite recent bullish analyst price target increases, a decline that sits at odds with the sell-side's improving view of the stock. Royalty Pharma (NASDAQ:RPRX) shares are declining sharply, tracking broad weakness in the healthcare sector, which …